{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:12:42Z","timestamp":1783465962565,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We compared the efficacy and safety of ultrasound (US)-guided radiofrequency ablation (RFA) and parathyroidectomy (PTX) for the treatment of secondary hyperparathyroidism (SHPT). In this single-center retrospective study, we divided patients into PTX (n\u2009=\u200953) and RFA (n\u2009=\u200947) groups. The primary outcome was the proportion of patients who achieved the target intact parathyroid hormone (iPTH) concentration range (\u2264\u2009300\u00a0pg\/mL). Secondary outcomes were the differences in the changes in iPTH, calcium, and phosphorus levels over time and prognosis. iPTH concentrations of 82.1% and 64.1% in the PTX and RFA groups, respectively, were within the recommended range at the endpoint (P\u2009=\u20090.07). iPTH concentrations in the PTX and RFA groups dropped sharply after treatment (82\u2009\u00b1\u2009163\u00a0pg\/mL and 280\u2009\u00b1\u2009307\u00a0pg\/mL, respectively, P\u2009&lt;\u20090.001). There was no difference in the trends of iPTH, calcium, and phosphorus levels between the two groups (P\u2009&gt;\u20090.05). Survival analysis revealed no differences in all-cause mortality and cumulative response rate between the two groups (P\u2009=\u20090.90, P\u2009=\u20090.14, respectively). Notably, the incidence of infection and length of the hospital stay in the RFA group were significantly lower. The preoperative bone-specific alkaline phosphatase concentration was a risk factor for postoperative hypocalcemia. US-guided RFA is minimally invasive and compared to PTX in terms of long-term efficacy and complications in the treatment of severe SHPT in maintenance dialysis patients. It may be used as an alternative technique to PTX; however, further studies are needed.<\/jats:p>","DOI":"10.1038\/s41598-022-14623-x","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T10:11:00Z","timestamp":1655547060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study"],"prefix":"10.1038","volume":"12","author":[{"given":"Mian","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"14623_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham, J., Locatelli, F. & Rodriguez, M. Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options. Clin. J. Am. Soc. Nephrol. 6, 913\u2013921 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"14623_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-015-0266-9","volume":"13","author":"EW Davies","year":"2015","unstructured":"Davies, E. W. et al. Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual. Life Outcomes 13, 1\u201311 (2015).","journal-title":"Health Qual. Life Outcomes"},{"key":"14623_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori, F. et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS study. Clin. J. Am. Soc. Nephrol. 10, 98\u2013109 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"14623_CR4","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/ndt\/gfv334","volume":"30","author":"KM Ivarsson","year":"2015","unstructured":"Ivarsson, K. M. et al. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol. Dial. Transplant. 30, 2027\u20132033 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14623_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060519897505","volume":"48","author":"J Liu","year":"2020","unstructured":"Liu, J., Huang, Q., Yang, M., Huang, L. & Zhang, L. Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. J. Int. Med. Res. 48, 1. https:\/\/doi.org\/10.1177\/0300060519897505 (2020).","journal-title":"J. Int. Med. Res."},{"key":"14623_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/02656736.2021.1945689","volume":"38","author":"Y Wei","year":"2021","unstructured":"Wei, Y. et al. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: A multicenter retrospective study. Int. J. Hyperth. 38, 1023\u20131030 (2021).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1080\/02656736.2019.1684576","volume":"36","author":"Z Hu","year":"2019","unstructured":"Hu, Z. et al. Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism. Int. J. Hyperth. 36, 1129\u20131136 (2019).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2169\/internalmedicine.52.8454","volume":"52","author":"R Wang","year":"2013","unstructured":"Wang, R., Jiang, T., Chen, Z. & Chen, J. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern. Med. 52, 583\u2013587 (2013).","journal-title":"Intern. Med."},{"key":"14623_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3803\/EnM.2013.28.3.231","volume":"28","author":"H-S Kim","year":"2013","unstructured":"Kim, H.-S. et al. Delayed surgery for parathyroid adenoma misdiagnosed as a thyroid nodule and treated with radiofrequency ablation. Endocrinol. Metab. 28, 231 (2013).","journal-title":"Endocrinol. Metab."},{"key":"14623_CR10","first-page":"946","volume":"33","author":"G Wang","year":"2017","unstructured":"Wang, G. et al. Microwave ablation: An effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis. Int. J. Hyperth. 33, 946\u2013952 (2017).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/02656736.2020.1744741","volume":"37","author":"XJ Cao","year":"2020","unstructured":"Cao, X. J. et al. Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: Systematic review and meta-analysis. Int. J. Hyperth. 37, 316\u2013323 (2020).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hed.24657","volume":"39","author":"C Peng","year":"2017","unstructured":"Peng, C. et al. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck 39, 564\u2013571 (2017).","journal-title":"Head Neck"},{"key":"14623_CR13","first-page":"835","volume":"36","author":"F Liu","year":"2019","unstructured":"Liu, F. et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int. J. Hyperth. 36, 835\u2013840 (2019).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/02656736.2021.1885754","volume":"38","author":"Z Diao","year":"2021","unstructured":"Diao, Z. et al. Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: A retrospective multicenter study. Int. J. Hyperth. 38, 213\u2013219 (2021).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/hdi.12740","volume":"23","author":"B Jiang","year":"2019","unstructured":"Jiang, B. et al. Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients. Hemodial. Int. 23, 247\u2013253 (2019).","journal-title":"Hemodial. Int."},{"key":"14623_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/0886022X.2020.1841655","volume":"42","author":"K Kritmetapak","year":"2020","unstructured":"Kritmetapak, K. et al. Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism. Ren. Fail. 42, 1118\u20131126 (2020).","journal-title":"Ren. Fail."},{"key":"14623_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/02656736.2020.1785557","volume":"37","author":"Y Wei","year":"2020","unstructured":"Wei, Y. et al. Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: A retrospective study. Int. J. Hyperth. 37, 819\u2013825 (2020).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-63299-8","volume":"10","author":"Z Zeng","year":"2020","unstructured":"Zeng, Z. et al. Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: Single session vs. two-session for effect on hypocalcemia. Sci. Rep. 10, 1\u201310 (2020).","journal-title":"Sci. Rep."},{"key":"14623_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/jbmr.3934","volume":"35","author":"Y Wei","year":"2020","unstructured":"Wei, Y., Peng, L., Zhao, Z., Li, Y. & Yu, M. Risk factors of severe hypocalcemia after US-guided percutaneous microwave ablation of the parathyroid gland in patients with secondary hyperparathyroidism. J. Bone Miner. Res. 35, 691\u2013697 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"14623_CR20","doi-asserted-by":"publisher","first-page":"c80","DOI":"10.1159\/000151722","volume":"110","author":"L Viaene","year":"2008","unstructured":"Viaene, L. et al. Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism. Nephron Clin. Pract. 110, c80\u2013c85 (2008).","journal-title":"Nephron Clin. Pract."},{"key":"14623_CR21","unstructured":"Indd, K. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). http:\/\/www.kisupplements.org (2017)."},{"key":"14623_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","volume":"70","author":"T Isakova","year":"2017","unstructured":"Isakova, T. et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Am. J. Kidney Dis. 70, 737\u2013751 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"14623_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa, M. et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther. Apher. Dial. 17, 247\u2013288 (2013).","journal-title":"Ther. Apher. Dial."},{"key":"14623_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00423-018-1726-6","volume":"403","author":"WY van der Plas","year":"2018","unstructured":"van der Plas, W. Y. et al. Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands. Langenbeck\u2019s Arch. Surg. 403, 999\u20131005 (2018).","journal-title":"Langenbeck\u2019s Arch. Surg."},{"key":"14623_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/0886022X.2016.1184924","volume":"38","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: A systematic review and meta-analysis. Ren. Fail. 38, 1050\u20131058 (2016).","journal-title":"Ren. Fail."},{"key":"14623_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22696","volume":"33","author":"J Wan","year":"2019","unstructured":"Wan, J., Li, W. & Zhong, Y. Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism. J. Clin. Lab. Anal. 33, e22696 (2019).","journal-title":"J. Clin. Lab. Anal."},{"key":"14623_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/02656736.2019.1566580","volume":"36","author":"X Li","year":"2019","unstructured":"Li, X., An, C., Yu, M. & Peng, L. Us-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: A pilot study. Int. J. Hyperth. 36, 322\u2013327 (2019).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/02656736.2018.1528392","volume":"36","author":"L Zhuo","year":"2019","unstructured":"Zhuo, L. et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection. Int. J. Hyperth. 36, 29\u201335 (2019).","journal-title":"Int. J. Hyperth."},{"key":"14623_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1148\/radiol.2016151875","volume":"282","author":"L Zhuo","year":"2017","unstructured":"Zhuo, L. et al. Us-guided microwave ablation of hyperplastic parathyroid glands: Safety and efficacy in patients with end-stage renal disease\u2014A pilot study. Radiology 282, 576\u2013584 (2017).","journal-title":"Radiology"},{"key":"14623_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijsu.2019.08.004","volume":"70","author":"L Gong","year":"2019","unstructured":"Gong, L., Tang, W., Lu, J. & Xu, W. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: A meta-analysis. Int. J. Surg. 70, 13\u201318 (2019).","journal-title":"Int. J. Surg."},{"key":"14623_CR31","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1210\/clinem\/dgab240","volume":"106","author":"Y Wei","year":"2021","unstructured":"Wei, Y. et al. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: A multicenter study. J. Clin. Endocrinol. Metab. 106, 2707\u20132717 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"14623_CR32","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1093\/ndt\/13.12.3111","volume":"13","author":"S Fletcher","year":"1998","unstructured":"Fletcher, S. et al. Nephrology Dialysis Transplantation Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol. Dial. Transplant. 13, 3111\u20133117 (1998).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14623_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/jrms.JRMS_553_19","volume":"25","author":"A Yazdani","year":"2020","unstructured":"Yazdani, A. et al. Ultrasound-guided ethanol injection for the treatment of parathyroid adenoma: A prospective self-controlled study. J. Res. Med. Sci. 25, 93 (2020).","journal-title":"J. Res. Med. Sci."},{"key":"14623_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2004-812939","volume":"25","author":"S Schamp","year":"2004","unstructured":"Schamp, S. et al. Ultrasound-guided percutaneous ethanol ablation of parathyroid hyperplasia: Preliminary experience in patients on chronic dialysis. Ultraschall Med. 25, 131\u2013136 (2004).","journal-title":"Ultraschall Med."},{"key":"14623_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243864","volume":"16","author":"L He","year":"2021","unstructured":"He, L. et al. Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules: Systematic review and network meta-analysis of randomized controlled trials. PLoS\u00a0One 16, e0243864 (2021).","journal-title":"PLoS\u00a0One"},{"key":"14623_CR36","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3348\/kjr.2020.0037","volume":"21","author":"EJ Ha","year":"2020","unstructured":"Ha, E. J., Baek, J. H. & Baek, S. M. Minimally invasive treatment for benign parathyroid lesions: Treatment efficacy and safety based on nodule characteristics. Korean J. Radiol. 21, 1388\u20131397 (2020).","journal-title":"Korean J. Radiol."},{"key":"14623_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21186846","volume":"21","author":"CY Hsu","year":"2020","unstructured":"Hsu, C. Y., Chen, L. R. & Chen, K. H. Osteoporosis in patients with chronic kidney diseases: A systemic review. Int. J. Mol. Sci. 21, 1\u201324 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"14623_CR38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.kint.2021.05.024","volume":"100","author":"SM Ott","year":"2021","unstructured":"Ott, S. M., Malluche, H. H., Jorgetti, V. & Elder, G. J. Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. Kidney Int. 100, 502\u2013505 (2021).","journal-title":"Kidney Int."},{"key":"14623_CR39","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.06.031","author":"C Ginsberg","year":"2021","unstructured":"Ginsberg, C. & Ix, J. H. Diagnosis and management of osteoporosis in advanced kidney disease: A review. Am. J. Kidney Dis. https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.031 (2021).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14623-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:42:36Z","timestamp":1669354956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14623-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14623"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14623-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10289"}}